Haleon plc

Headquarters: Weybridge, United Kingdom

Founded: 18 July 2022

CEO: Brian McNamara

show_chart LSE: HLN +2.12%

Market Cap

£29.90 Billion

GBP as of July 1, 2023

US$37.99 Billion

history Market Cap History

Haleon plc market capitalization over time

Evolution of Haleon plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Haleon plc

Detailed Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Stocks & Indices

Haleon plc has the following listings and related stock indices.

Stock: LSE: HLN

Stock: NYSE: HLN

Product & Services

Oral hygiene and medicines, nutritional products, over-the-counter medicines



Building 5

First Floor The Heights

Weybridge, KT13 0NY

United Kingdom

Phone: 44 1932 822000